Results 11 to 20 of about 1,229,815 (249)

Concept of defibrillation vector in the management of high defibrillation threshold. [PDF]

World J Cardiol, 2013
We present a case where defibrillation threshold was dangerously elevated to the point that the patient had no safety margin, and his implantable cardioverter-defibrillator generator was discovered to have migrated.
Hayes K, Deshmukh A, Pant S, Tobler G, Paydak H.   +4 more
europepmc   +4 more sources

Rise in defibrillation threshold after postoperative cardiac remodeling in a patient with severe Ebstein’s anomaly [PDF]

HeartRhythm Case Reports, 2017
Reina Bianca Tan, MD, Charles Love, MD, FHRS, Dan Halpern, MD, Frank Cecchin, MD   +3 more
doaj   +4 more sources

Editorial to “Can lead damage be ruled out using defibrillation threshold testing in patients with very high‐impedance shock leads?” [PDF]

Journal of Arrhythmia
Yoshinari Enomoto
doaj   +6 more sources

Left-Sided Humerus Fracture as an Unusual Complication of Defibrillation Threshold Testing Following S-ICD Implantation [PDF]

JACC: Case Reports, 2020
Comminuted subcapital humerus fracture as a complication of subcutaneous implantable cardioverter-defibrillator insertion is related to an abducted and externally rotated arm position during the defibrillation threshold test at which the current pathway ...
Jan Elders, MA, Hisham AlHashimi, MD
doaj   +2 more sources

Effect of ventricular myocardium characteristics on the defibrillation threshold. [PDF]

Technol Health Care, 2018
Myocardium characteristics differ markedly among individuals and play an important role in defibrillation threshold. The accuracy of simulation models used in most published studies are still have room to be improved and most of them only discussed the ...
Qian L, Wang J, Jin L, Song B, Wu X.
europepmc   +2 more sources

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator. [PDF]

J Innov Card Rhythm Manag, 2017
There are limited data regarding defibrillation thresholds (DFTs) for the subcutaneous implantable cardioverter-defibrillator (S-ICD), and factors associated with elevated DFTs remain incompletely understood.
Do K, Chang P, Konecny T, Carlson SK, Tun H, Huntsinger M, Doshi RN.   +6 more
europepmc   +2 more sources

Decreased Defibrillation Threshold and Minimized Myocardial Damage With Left Axilla Implantable Cardioverter Defibrillator Implantation.

Circulation Journal, 2016
BACKGROUND To reduce myocardial damage caused by implantable cardioverter defibrillator (ICD) shock, the left axilla was studied as an alternative pulse generator implantation site, and compared with the traditional implantation site, the left anterior ...
M. Noro, Xin Zhu, Yoshinari Enomoto, Yasuhiro Oikawa, Hiroyuki Tatsunami, Rina Ishii, Yasutake Toyoda, Masako Asami, N. Sahara, Takahito Takagi, Yuriko Narabayashi, Hikari Hashimoto, Naoshi Ito, S. Kujime, T. Sakai, Keijiro Nakamura, T. Sakata, H. Abe, K. Sugi   +18 more
semanticscholar   +3 more sources

Defibrillation Threshold Testing After ICD Implantation in Patients with Chronic Kidney Disease [PDF]

Cardiology and Therapy
Introduction Routine defibrillation threshold (DFT) testing at the time of implantable cardioverter-defibrillator (ICD) implantation is no longer recommended because testing did not improve shock efficacy or reduce arrhythmic death.
Rohit J. Timal, Lano Osman, Joris I. Rotmans, Marianne Bootsma, Bart Mertens, Martin J. Schalij, Ton J. Rabelink, J. Wouter Jukema   +7 more
doaj   +2 more sources

Defibrillation Threshold [PDF]

Definitions, 2020

semanticscholar   +2 more sources

Fabry cardiomyopathy presenting with a high defibrillation threshold: A short case report [PDF]

Journal of Arrhythmia, 2015
Fabry disease is an X-linked recessive glycosphingolipid storage disorder caused by a deficiency of lysosomal enzyme α-galactosidase A. It is recognized that Fabry disease patients often have ventricular arrhythmias.
Takashi Kanda, MD, Masaharu Masuda, MD, Akihiro Sunaga, MD, Masashi Fujita, MD, PhD, Osamu Iida, MD, Shin Okamoto, MD, Takayuki Ishihara, MD, Kiyonori Nanto, MD, Tatsuya Shiraki, MD, Fusako Sera, MD, Masaaki Uematsu, MD, PhD   +10 more
doaj   +2 more sources